A case of angiosarcoma of the scalp.
Toru NISHIDA, Naoko Okazaki, Yuko ABE, Yoshihiko Mitsuhashi, Shigeo Kondô
Abstract
Open-access reader
Toru NISHIDA, Naoko Okazaki, Yuko ABE, Yoshihiko Mitsuhashi, Shigeo Kondô
Abstract
Open-access reader
Angiosarcoma of the scalp is a relatively rare skin malignant disorder. We experienced a case of angiosarcoma. A 74-year-old woman admitted our hospital with a tumor which had appeared 1 month before on her right frontal scalp. Three months ago she got injures for two times on the scalp where exact same place the tumor appeared. She was diagnosed as angiosarcoma by typical clinical and histopathological features. She was intensively treated with rIL-2 and surgical operation. Intra-arterial infusion of rIL-2 was carried out before the operation. After the operation she was treated with intra-venous infusion of rIL-2. At the time of beginning the treatment, diameter of the tumor was 5cm and decreased to 3cm just before the operation. We estimated the IL-2 therapy benefitable for decreasing the tumor-size. No recurence is observed until now. [Skin Cancer (Japan) 2000; 15 : 276-279]
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Angiosarcoma of the scalp is a relatively rare skin malignant disorder. We experienced a case of angiosarcoma. A 74-year-old woman admitted our hospital with a tumor which had appeared 1 month before on her right frontal scalp. Three months ago she got injures for two times on the scalp where exact same place the tumor appeared. She was diagnosed as angiosarcoma by typical clinical and histopathological features. She was intensively treated with rIL-2 and surgical operation. Intra-arterial infusion of rIL-2 was carried out before the operation. After the operation she was treated with intra-venous infusion of rIL-2. At the time of beginning the treatment, diameter of the tumor was 5cm and decreased to 3cm just before the operation. We estimated the IL-2 therapy benefitable for decreasing the tumor-size. No recurence is observed until now. [Skin Cancer (Japan) 2000; 15 : 276-279]
Key concepts: Angiosarcoma, Scalp, Medicine, Surgery, Hemangiosarcoma, Cancer, Internal medicine